{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:12:44Z","timestamp":1790712764165,"version":"4.1.0"},"reference-count":50,"publisher":"American Society of Hematology","issue":"12","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,25]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Mycosis fungoides (MF) is the most prevalent primary cutaneous T-cell lymphoma, with an indolent or aggressive course and poor survival. The pathogenesis of MF remains unclear, and prognostic factors in the early stages are not well established. Here, we characterized the most recurrent genomic alterations using whole-exome sequencing of 67 samples from 48 patients from Lille University Hospital (France), including 18 sequential samples drawn across stages of the malignancy. Genomic data were analyzed on the Broad Institute\u2019s Terra bioinformatics platform. We found that gain7q, gain10p15.1 (IL2RA and IL15RA), del10p11.22 (ZEB1), or mutations in JUNB and TET2 are associated with high-risk disease stages. Furthermore, gain7q, gain10p15.1 (IL2RA and IL15RA), del10p11.22 (ZEB1), and del6q16.3 (TNFAIP3) are coupled with shorter survival. Del6q16.3 (TNFAIP3) was a risk factor for progression in patients at low risk. By analyzing the clonal heterogeneity and the clonal evolution of the cohort, we defined different phylogenetic pathways of the disease with acquisition of JUNB, gain10p15.1 (IL2RA and IL15RA), or del12p13.1 (CDKN1B) at progression. These results establish the genomics and clonality of MF and identify potential patients at risk of progression, independent of their clinical stage.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023012125","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T19:14:34Z","timestamp":1711048474000},"page":"3109-3119","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":21,"title":["Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4140-475X","authenticated-orcid":false,"given":"L\u00e9a","family":"Fl\u00e9chon","sequence":"first","affiliation":[{"name":"1Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7062-9814","authenticated-orcid":false,"given":"In\u00e8s","family":"Arib","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Lille Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2535-3729","authenticated-orcid":false,"given":"Ankit K.","family":"Dutta","sequence":"additional","affiliation":[{"name":"3Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA"},{"name":"4Department of Medical Oncology, Harvard Medical School, Boston, MA"},{"name":"5Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2561-9980","authenticated-orcid":false,"given":"Lama","family":"Hasan Bou Issa","sequence":"additional","affiliation":[{"name":"1Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8025-9850","authenticated-orcid":false,"given":"Romanos","family":"Sklavenitis-Pistofidis","sequence":"additional","affiliation":[{"name":"3Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA"},{"name":"4Department of Medical Oncology, Harvard Medical School, Boston, MA"},{"name":"5Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1739-2162","authenticated-orcid":false,"given":"R\u00e9mi","family":"Tilmont","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Lille Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2245-9552","authenticated-orcid":false,"given":"Chip","family":"Stewart","sequence":"additional","affiliation":[{"name":"5Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6990-7354","authenticated-orcid":false,"given":"Romain","family":"Dubois","sequence":"additional","affiliation":[{"name":"6Department of Pathology, Lille Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1792-7270","authenticated-orcid":false,"given":"St\u00e9phanie","family":"Poulain","sequence":"additional","affiliation":[{"name":"1Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France"},{"name":"7Department of Hematology, Biology and Pathology Center, Lille Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4729-7054","authenticated-orcid":false,"given":"Marie-Christine","family":"Copin","sequence":"additional","affiliation":[{"name":"8Department of Pathology, Angers University, Angers Hospital, INSERM, CRCI2NA, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1649-9577","authenticated-orcid":false,"given":"Sahir","family":"Javed","sequence":"additional","affiliation":[{"name":"9Department of Medical Oncology, Valenciennes Hospital, Valenciennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9100-2316","authenticated-orcid":false,"given":"Morgane","family":"Nudel","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Lille Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4836-7237","authenticated-orcid":false,"given":"Doriane","family":"Cavalieri","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Lille Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3151-9441","authenticated-orcid":false,"given":"Guillaume","family":"Escure","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Lille Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Gower","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Lille Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6326-9283","authenticated-orcid":false,"given":"Paul","family":"Chauvet","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Lille Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3449-6676","authenticated-orcid":false,"given":"Nicolas","family":"Gazeau","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Lille Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Saade","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Lille Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1387-0510","authenticated-orcid":false,"given":"Marietou Binta","family":"Thiam","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Lille Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7048-5555","authenticated-orcid":false,"given":"A\u00efcha","family":"Ouelkite-Oumouchal","sequence":"additional","affiliation":[{"name":"1Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2685-1108","authenticated-orcid":false,"given":"Silvia","family":"Gaggero","sequence":"additional","affiliation":[{"name":"1Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5343-6471","authenticated-orcid":false,"given":"\u00c9meline","family":"Cailliau","sequence":"additional","affiliation":[{"name":"10Department of Biostatistics, Lille Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Faiz","sequence":"additional","affiliation":[{"name":"11Department of Pathology and Dermatology, Lille Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7788-6132","authenticated-orcid":false,"given":"Olivier","family":"Carpentier","sequence":"additional","affiliation":[{"name":"11Department of Pathology and Dermatology, Lille Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3927-1022","authenticated-orcid":false,"given":"Nicolas","family":"Duployez","sequence":"additional","affiliation":[{"name":"1Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France"},{"name":"7Department of Hematology, Biology and Pathology Center, Lille Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5893-9131","authenticated-orcid":false,"given":"Thierry","family":"Idziorek","sequence":"additional","affiliation":[{"name":"1Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2644-1790","authenticated-orcid":false,"given":"Laurent","family":"Mortier","sequence":"additional","affiliation":[{"name":"11Department of Pathology and Dermatology, Lille Hospital, Lille, France"},{"name":"12OncoThai unit, INSERM UMR-S1189, Lille University, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8523-3708","authenticated-orcid":false,"given":"Martin","family":"Figeac","sequence":"additional","affiliation":[{"name":"13Lille University, Lille Hospital, CNRS, INSERM, Institut Pasteur de Lille, US 41 \u2013 UAR 2014 - PLBS, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1267-9546","authenticated-orcid":false,"given":"Claude","family":"Preudhomme","sequence":"additional","affiliation":[{"name":"1Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France"},{"name":"7Department of Hematology, Biology and Pathology Center, Lille Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6563-2709","authenticated-orcid":false,"given":"Bruno","family":"Quesnel","sequence":"additional","affiliation":[{"name":"1Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France"},{"name":"2Department of Hematology, Lille Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3426-371X","authenticated-orcid":false,"given":"Suman","family":"Mitra","sequence":"additional","affiliation":[{"name":"1Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3714-9824","authenticated-orcid":false,"given":"Franck","family":"Morschhauser","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Lille Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0936-0753","authenticated-orcid":false,"given":"Gad","family":"Getz","sequence":"additional","affiliation":[{"name":"5Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA"},{"name":"14Cancer Center and Department of Pathology, Massachusetts General Hospital, Boston, MA"},{"name":"15Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7361-3092","authenticated-orcid":false,"given":"Irene M.","family":"Ghobrial","sequence":"additional","affiliation":[{"name":"3Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA"},{"name":"4Department of Medical Oncology, Harvard Medical School, Boston, MA"},{"name":"15Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7653-711X","authenticated-orcid":false,"given":"Salomon","family":"Manier","sequence":"additional","affiliation":[{"name":"1Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France"},{"name":"2Department of Hematology, Lille Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"issue":"Suppl 3","key":"2024062514354532900_bib1","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1080\/10428190310001623766","article-title":"Cutaneous T-cell lymphoma: epidemiology, etiology, and classification","volume":"44","author":"Willemze","year":"2003","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"2024062514354532900_bib2","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"issue":"6","key":"2024062514354532900_bib3","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and S\u00e9zary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"issue":"4","key":"2024062514354532900_bib4","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1182\/blood.V92.4.1150","article-title":"Transformation of mycosis fungoides\/sezary syndrome: clinical characteristics and prognosis","volume":"92","author":"Diamandidou","year":"1998","journal-title":"Blood"},{"issue":"7","key":"2024062514354532900_bib5","first-page":"2212","article-title":"Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases","volume":"95","author":"Vergier","year":"2000","journal-title":"Blood"},{"issue":"7","key":"2024062514354532900_bib6","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood-2011-08-376319","article-title":"Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases","volume":"119","author":"Benner","year":"2012","journal-title":"Blood"},{"issue":"13","key":"2024062514354532900_bib7","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1182\/blood-2013-05-504308","article-title":"PLCG1 mutations in cutaneous T-cell lymphomas","volume":"123","author":"Vaqu\u00e9","year":"2014","journal-title":"Blood"},{"issue":"9","key":"2024062514354532900_bib8","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1038\/jid.2015.161","article-title":"PLCG1 gene mutations are uncommon in cutaneous T-cell lymphomas","volume":"135","author":"Caumont","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"issue":"9","key":"2024062514354532900_bib9","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/ng.3370","article-title":"Genomic analysis of mycosis fungoides and S\u00e9zary syndrome identifies recurrent alterations in TNFR2","volume":"47","author":"Ungewickell","year":"2015","journal-title":"Nat Genet"},{"issue":"12","key":"2024062514354532900_bib10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/gcc.22679","article-title":"Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides","volume":"57","author":"Bastidas Torres","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"2024062514354532900_bib11","first-page":"1104","article-title":"Allelic deletion at 9p21-22 in primary cutaneous CD30+ large cell lymphoma","volume":"115","author":"B\u00f6ni","year":"2000","journal-title":"J\u00a0Invest Dermatol"},{"issue":"4","key":"2024062514354532900_bib12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/modpathol.2009.196","article-title":"CDKN2A\u2013CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma","volume":"23","author":"Laharanne","year":"2010","journal-title":"Mod Pathol"},{"issue":"3","key":"2024062514354532900_bib13","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bjd.13476","article-title":"Diagnostic and prognostic significance of CDKN2A\/CDKN2B deletions in patients with transformed mycosis fungoides and primary cutaneous CD30-positive lymphoproliferative disease","volume":"172","author":"Nicolae-Cristea","year":"2015","journal-title":"Br J Dermatol"},{"key":"2024062514354532900_bib14","unstructured":"Andrews\n              S\n            , FastQC. A quality control tool for high throughput sequence data. 2010. Accessed 22 November 2022. https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/."},{"issue":"19","key":"2024062514354532900_bib15","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","article-title":"MultiQC: summarize analysis results for multiple tools and samples in a single report","volume":"32","author":"Ewels","year":"2016","journal-title":"Bioinformatics"},{"issue":"1","key":"2024062514354532900_bib16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet J"},{"key":"2024062514354532900_bib17","article-title":"Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM","author":"Li","year":"2013","journal-title":"arXiv"},{"key":"2024062514354532900_bib18","unstructured":"Picard Tools (Broad Institute, Cambridge, MA). Version 2.27.5 (October 7, 2022). Accessed 12 February 2023. http:\/\/broadinstitute.github.io\/picard\/."},{"issue":"1110","key":"2024062514354532900_bib19","first-page":"11.10.1","article-title":"From fastQ data to high-confidence variant calls: the genome analysis toolkit best practices pipeline","volume":"43","author":"Van der Auwera","year":"2013","journal-title":"Curr Protoc Bioinformatics"},{"key":"2024062514354532900_bib20","author":"Van der Auwera","year":"2020"},{"issue":"4","key":"2024062514354532900_bib21","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol"},{"issue":"3","key":"2024062514354532900_bib22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nbt.2514","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples","volume":"31","author":"Cibulskis","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"14","key":"2024062514354532900_bib23","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/bioinformatics\/bts271","article-title":"Strelka: accurate somatic small-variant calling from sequenced tumor\u2013normal sample pairs","volume":"28","author":"Saunders","year":"2012","journal-title":"Bioinformatics"},{"key":"2024062514354532900_bib24","doi-asserted-by":"publisher","DOI":"10.1101\/861054","article-title":"Calling somatic SNVs and indels with mutect2","author":"Benjamin","year":"2  2019","journal-title":"bioRxiv"},{"issue":"7484","key":"2024062514354532900_bib25","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","author":"Lawrence","year":"2014","journal-title":"Nature"},{"issue":"1","key":"2024062514354532900_bib26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The ensembl variant effect predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol"},{"issue":"4","key":"2024062514354532900_bib27","doi-asserted-by":"crossref","first-page":"E2423","DOI":"10.1002\/humu.22771","article-title":"Oncotator: cancer variant annotation tool","volume":"36","author":"Ramos","year":"2015","journal-title":"Hum Mutat"},{"issue":"7457","key":"2024062514354532900_bib28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"issue":"5","key":"2024062514354532900_bib29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nbt.2203","article-title":"Absolute quantification of somatic DNA alterations in human cancer","volume":"30","author":"Carter","year":"2012","journal-title":"Nat Biotechnol"},{"issue":"5","key":"2024062514354532900_bib30","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"issue":"26","key":"2024062514354532900_bib31","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1182\/blood.2019000626","article-title":"Recurrent MSCE116K mutations in ALK-negative anaplastic large cell lymphoma","volume":"133","author":"Luchtel","year":"2019","journal-title":"Blood"},{"issue":"14","key":"2024062514354532900_bib32","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood.2020009655","article-title":"Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneity","volume":"138","author":"Park","year":"2021","journal-title":"Blood"},{"issue":"10","key":"2024062514354532900_bib33","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1600-0560.2007.00924.x","article-title":"A\u00a0genomic and expression study of AP-1 in primary cutaneous T-cell lymphoma: evidence for dysregulated expression of JUNB and JUND in MF and SS","volume":"35","author":"Mao","year":"2008","journal-title":"J\u00a0Cutan Pathol"},{"issue":"4","key":"2024062514354532900_bib34","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1182\/blood-2002-08-2434","article-title":"Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas","volume":"101","author":"Mao","year":"2003","journal-title":"Blood"},{"issue":"18","key":"2024062514354532900_bib35","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1182\/blood.2019791475","article-title":"Dysregulation of the TET family of epigenetic regulators in lymphoid and myeloid malignancies","volume":"134","author":"Lio","year":"2019","journal-title":"Blood"},{"issue":"1","key":"2024062514354532900_bib36","doi-asserted-by":"crossref","first-page":"15483","DOI":"10.1038\/s41598-020-72459-9","article-title":"Independent evolution of cutaneous lymphoma subclones in different microenvironments of the skin","volume":"10","author":"Iyer","year":"2020","journal-title":"Sci Rep"},{"issue":"11","key":"2024062514354532900_bib37","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/bloodadvances.2020001441","article-title":"Branched evolution and genomic intratumor heterogeneity in the pathogenesis of cutaneous T-cell lymphoma","volume":"4","author":"Iyer","year":"2020","journal-title":"Blood Adv"},{"issue":"12","key":"2024062514354532900_bib38","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/ng.3442","article-title":"The mutational landscape of cutaneous T-cell lymphoma and S\u00e9zary syndrome","volume":"47","author":"da Silva Almeida","year":"2015","journal-title":"Nat Genet"},{"issue":"14","key":"2024062514354532900_bib39","doi-asserted-by":"crossref","first-page":"e147025","DOI":"10.1172\/JCI147025","article-title":"FOXA1 overexpression suppresses interferon signaling and immune response in cancer","volume":"131","author":"He","year":"2021","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"2024062514354532900_bib40","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jid.2019.07.693","article-title":"Frequent and persistent PLCG1 mutations in s\u00e9zary cells directly enhance PLC\u03b31 activity and stimulate NF\u03baB, AP-1, and NFAT signaling","volume":"140","author":"Patel","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"issue":"17","key":"2024062514354532900_bib41","doi-asserted-by":"crossref","first-page":"9148","DOI":"10.1073\/pnas.93.17.9148","article-title":"Activation of Jak\/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome","volume":"93","author":"Zhang","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2024062514354532900_bib42","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.leu.2402093","article-title":"Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells","volume":"15","author":"Eriksen","year":"2001","journal-title":"Leukemia"},{"issue":"3","key":"2024062514354532900_bib43","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.0022-202x.2001.01436.x","article-title":"Constitutive and interleukin-7- and interleukin-15-stimulated DNA binding of STAT and novel factors in cutaneous T cell lymphoma cells","volume":"117","author":"Qin","year":"2001","journal-title":"J\u00a0Invest Dermatol"},{"issue":"1","key":"2024062514354532900_bib44","doi-asserted-by":"crossref","first-page":"8866","DOI":"10.1038\/ncomms9866","article-title":"Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution","volume":"6","author":"Kasar","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"2024062514354532900_bib45","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1038\/s41598-021-83352-4","article-title":"Spectrum of mutational signatures in T-cell lymphoma reveals a key role for UV radiation in cutaneous T-cell lymphoma","volume":"11","author":"Jones","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"2024062514354532900_bib46","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1182\/blood-2014-11-611194","article-title":"Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides","volume":"126","author":"McGirt","year":"2015","journal-title":"Blood"},{"issue":"7574","key":"2024062514354532900_bib47","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse","volume":"526","author":"Landau","year":"2015","journal-title":"Nature"},{"issue":"9","key":"2024062514354532900_bib48","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ng.3356","article-title":"Genomic landscape of cutaneous T cell lymphoma","volume":"47","author":"Choi","year":"2015","journal-title":"Nat Genet"},{"issue":"11","key":"2024062514354532900_bib49","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41408-020-00380-5","article-title":"Targeted genomic analysis of cutaneous T cell lymphomas identifies a subset with aggressive clinicopathological features","volume":"10","author":"Argyropoulos","year":"2020","journal-title":"Blood Cancer J"},{"issue":"9","key":"2024062514354532900_bib50","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/ajh.25577","article-title":"Mycosis fungoides and S\u00e9zary syndrome: 2019 update on diagnosis, risk-stratification, and management","volume":"94","author":"Hristov","year":"2019","journal-title":"Am J Hematol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/12\/3109\/2232115\/blooda_adv-2023-012125-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/12\/3109\/2232115\/blooda_adv-2023-012125-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T14:37:22Z","timestamp":1719326242000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/12\/3109\/515386\/Genomic-profiling-of-mycosis-fungoides-identifies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,6,25]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023012125","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,13]]}}}